NF1 and Miyoshi myopathy: Although BRAF, RAS, KIT, NF1, and SF3B1 have been identified as significantly mutated genes [4], there remains a lack of understanding and identification of oncogenic drivers in MM, probably owing to the rarity of samples and lack of preclinical models.